Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
Background: Allopurinol is the most frequently used antihyperuricemic drug. Fenofibrate, a derivative of fibric acid, is commonly used in the treatment of hyperlipidemia. Fenofibrate treatment has been shown to decrease serum uric acid levels. This study was conducted to assess the efficacy and s...
Main Authors: | Irfan Zafar, Moosa Khan, Syed Mohsin Turab, Rafeeq Alam Khanz |
---|---|
Format: | Article |
Language: | English |
Published: |
Dow University of Health Sciences
2012-04-01
|
Series: | Journal of the Dow University of Health Sciences |
Subjects: | |
Online Access: | https://www.jduhs.com/index.php/jduhs/article/view/1527 |
Similar Items
-
Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01) -
Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01) -
Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01) -
Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial
by: Shuang Liu, et al.
Published: (2024-03-01) -
To treat or not to treat asymptomatic hyperuricemia
by: Hamid Mustafa
Published: (2014-01-01)